Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
298
Employees298
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2005
Founded2005
Employees
298
Employees298

SNDX Key Statistics

Market cap
2.11B
Market cap2.11B
Price-Earnings ratio
-6.70
Price-Earnings ratio-6.70
Dividend yield
Dividend yield
Average volume
1.28M
Average volume1.28M
High today
$24.84
High today$24.84
Low today
$21.68
Low today$21.68
Open price
$22.31
Open price$22.31
Volume
2.55M
Volume2.55M
52 Week high
$24.84
52 Week high$24.84
52 Week low
$8.58
52 Week low$8.58

Stock Snapshot

With a market cap of 2.11B, Syndax Pharmaceuticals(SNDX) trades at $24.70. The stock has a price-to-earnings ratio of -6.70.

On 2026-03-09, Syndax Pharmaceuticals(SNDX) stock moved within a range of $21.68 to $24.84. With shares now at $24.70, the stock is trading +13.9% above its intraday low and -0.6% below the session's peak.

Trading volume for Syndax Pharmaceuticals(SNDX) stock has reached 2.55M, versus its average volume of 1.28M.

Over the past 52 weeks, Syndax Pharmaceuticals(SNDX) stock has traded between a high of $24.84 and a low of $8.58.

Over the past 52 weeks, Syndax Pharmaceuticals(SNDX) stock has traded between a high of $24.84 and a low of $8.58.

SNDX News

TipRanks 2d
Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push

Syndax Pharmaceuticals Inc. ((SNDX)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium Unlock hedge fun...

Simply Wall St 5d
How Investors May Respond To Syndax Pharmaceuticals Shelf Offering And Revuforj Niktimvo Momentum

In late February 2026, Syndax Pharmaceuticals filed a US$77.73 million shelf registration for 3,746,239 common shares tied to an ESOP-related offering and sched...

How Investors May Respond To Syndax Pharmaceuticals Shelf Offering And Revuforj Niktimvo Momentum

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.